Showing results (971-980 of 1,047) with videos related to
Sort By:
Pageof 105
Personalized Medicine|June 11, 2011
Genotype-environment interactions and their translational implicationsTesfaye M Baye, Tilahun Abebe, Russell A WilkePersonalized Medicine|September 20, 2011
Genetic susceptibility to bladder cancer risk and outcomeJian Gu, Xifeng WuPersonalized Medicine|September 16, 2014
Translating personalized medicine using new genetic technologies in clinical practice: the ethical issuesKelly E Ormond, Mildred K ChoPersonalized Medicine|December 16, 2014
Recent advances in personalized lung cancer medicineRoss A Okimoto, Trever G BivonaPersonalized Medicine|January 21, 2015
Ethical, legal and social implications of incorporating personalized medicine into healthcareKyle B Brothers, Mark A RothsteinPersonalized Medicine|December 30, 2014
Considering race and the potential for ERG expression as a biomarker for prostate cancerIsaac J Powell, Gregory Dyson, Sreenivasa R Chinni, et al.Personalized Medicine|September 3, 2020
Universal tumor screening for lynch syndrome: perspectives of patients regarding willingness and informed consentAnusree Subramonian, Doug Smith, Elizabeth Dicks, et al.Personalized Medicine|November 7, 2019
Cost-effectiveness of BRCA1/2 mutation profiling to target olaparib use in patients with metastatic breast cancerShota Saito, Kyoko Nakazawa, Masayuki Nagahashi, et al.Personalized Medicine|November 6, 2019
Lipoprotein(a) as a marker for predicting coronary collateral circulation in patients with acute myocardial infarctionXiang-Dong You, Jing-Lu Jin, Hua Zhang, et al.Personalized Medicine|June 4, 2021
Expanded carrier screening in Flanders (Belgium): an online survey on the perspectives of nonpregnant reproductive-aged womenEva Van Steijvoort, Heleen Devolder, Inne Geysen, et al.Pageof 105